Ondansetron is an anti-sickness medicine (sometimes called an antiemetic) that is mainly used in hospitals to help with nausea and vomiting associated with cancer treatments or operations under ...
Please read this leaflet carefully before you use ONDANSETRON VIATRIS solution for injection. This leaflet answers some common questions about ONDANSETRON VIATRIS. It does not contain all the ...
More data indicating that ondansetron is not associated with an increase in most birth defects when taken for nausea and vomiting during the first trimester of pregnancy have emerged from an analysis ...
Relative efficacy of various 5- hydroxytryptamine receptor antagonists in the prevention and control of acute nausea and vomiting associated with platinum-based chemotherapy ...
Ondansetron given to relieve nausea and vomiting in pregnant women during the first trimester is associated with a low risk for birth defects, and possibly a small increase in the incidence of cardiac ...
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. In a double-blind, randomized, stratified, parallel-group study, the efficacy and safety of granisetron and ...
WASHINGTON -- The 32-mg dose of the anti-nausea drug ondansetron (Zofran) has been pulled from the market because of concerns about cardiac problems, the FDA announced Tuesday. Ondansetron is approved ...
Please provide your email address to receive an email when new articles are posted on . Postdischarge ondansetron reduced vomiting and disease severity among children with acute gastroenteritis.
Please read this leaflet carefully before you start taking ONDANSETRON ODT VIATRIS orally disintegrating tablets. This leaflet answers some common questions about ONDANSETRON ODT VIATRIS orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback